A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.
Clinical trial NCT07024407 · RECRUITING
Trial details
- NCT number
- NCT07024407
- Sponsor
- Ashibio Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-14
- Primary completion
- 2025-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.